FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to new compounds of formula
wherein: m, n, R0, R1, R2, R3 and R4 have the values presented in clause 1 of the patent claim provided the compound of formula (I) cannot represent N-methyl-1-(phenylsulphonyl)-1H-indole-4-methanamine.
EFFECT: compounds show 5-NT6 receptor antagonist activity that that allows them being used in the pharmaceutical composition.
19 cl, 3 tbl, 192 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED OXYDOL DERIVATIVES AND USE THEREOF AS VASOPRESSIN RECEPTOR LIGANDS | 2007 |
|
RU2461556C2 |
NEW CONJUGATES BINDING COMPOUND - ACTIVE COMPOUND (ADC) AND USE THEREOF | 2012 |
|
RU2610336C2 |
BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2597364C2 |
BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2589878C2 |
AMINOPYRIMIDINE DERIVATIVES AND USE THEREOF AS AROMATIC HYDROCARBON RECEPTOR MODULATORS | 2021 |
|
RU2826628C1 |
QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING SAME | 2011 |
|
RU2582610C2 |
DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS CONTAINING THEM, OBTAINING AND APPLICATION | 2004 |
|
RU2346938C2 |
AMINOPYRAZOLE DERIVATIVE | 2010 |
|
RU2580543C9 |
SULPHONAMIDE COMPOUNDS POSSESSING TRPM8 ANTAGONIST ACTIVITY | 2012 |
|
RU2563030C2 |
AMINOPYRIMIDINE KINASE INHIBITORS | 2010 |
|
RU2636589C2 |
Authors
Dates
2012-05-10—Published
2007-07-03—Filed